CONGRESS

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Dr. Andrés Rodríguez - 19 June, 2026 0

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide. Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Dr. Omar Tupayachi - 17 June, 2026 0

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Dr. Juan Manuel Pérez - 16 June, 2026 0

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy

SOLACI-SOCIME 2012 Día 1

Daily SOLACI-SBHCI Día 2

Daily SOLACI-SBHCI Día 1

Daily SOLACI-CACI Día 2

Daily SOLACI-CACI Día 2

Daily SOLACI-CACI Día 3

Daily SOLACI-CACI Día 1

SOURCE XT: Results at 2 years of SAPIEN XT valve

Last News

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Institutional News

Fellow’s Corner – Case 2: Acute Myocardial Infarction Due to Simultaneous Occlusion of Two Coronary Arteries

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

Guatemala Sessions 2026 – Young Interventional Cardiologists Contest – Submit Your Case

Access